SaudiVax intends to be the premier developer, manufacturer, and supplier of vaccines and biologics in Saudi Arabia and the MENA region, including halal vaccines. Co-Founder and Managing Director Professor Mazen Hassanain comments on the company’s ambitions, the opportunity that halal vaccines represent, how its J&J partnership will create the first tech transfer for biologics manufacturing in Saudi Arabia, and how its Merck partnership will move SaudiVax closer to its goal of offering world-class CDMO services.
As a country, Saudi Arabia wants to match the well-established regulatory systems of North America, Europe, and Japan, but adding a halal component, which is of great value to Muslims, one of the largest religious groups in the world.
